Molecular Biology Reports

, Volume 40, Issue 2, pp 1325–1332

Serum microRNA expression profile as a biomarker for the diagnosis of pertussis

  • Yiyue Ge
  • Kangchen Zhao
  • Yuhua Qi
  • Xiaoyan Min
  • Zhiyang Shi
  • Xian Qi
  • Yunfeng Shan
  • Lan Cui
  • Minghao Zhou
  • Yong Wang
  • Hua Wang
  • Lunbiao Cui
Article

Abstract

Pertussis is a highly contagious, respiratory disease associated with substantial morbidity and mortality. A rapid and reliable diagnostic method is essential for appropriate treatment and prevention. Expression profiles of circulating microRNAs (miRNAs) have been proven as new non-invasive biomarkers for infectious diseases. We aimed to investigated the serum miRNA profile in pertussis patients and explored its potential as a novel diagnostic biomarker for pertussis. Among 664 different miRNAs analyzed using a miRNA array, 50 were overexpressed and 81 were underexpressed in the serum of pertussis patients. Expression levels of seven candidate miRNAs were further evaluated by real-time qRT-PCR. A panel of five miRNAs (miR-202, miR-342-5p, miR-206, miR-487b, miR-576-5p) was confirmed overexpressed in pertussis patients (p < 0.05). Risk score and receiver-operating characteristic (ROC) analysis showed that the area under the curve of the five-member miRNA profile was 0.980. At an optimal cutoff value (0.707), this panel of miRNAs yielded a sensitivity of 97.4 % and a specificity of 94.3 %. These data suggest that the five-member serum miRNA profile may serve as a new biomarker for pertussis diagnosis with high specificity and sensitivity.

Keywords

Serum microRNA Profile Pertussis Biomarker Diagnosis 

Supplementary material

11033_2012_2176_MOESM1_ESM.doc (74 kb)
Supplementary material 1 (DOC 74 kb)
11033_2012_2176_MOESM2_ESM.doc (103 kb)
Supplementary material 2 (DOC 103 kb)

References

  1. 1.
    Plotkin S (2005) The global pertussis initiative: process overview. Pediatr Infect Dis J 24(5 Suppl):S7–S9PubMedGoogle Scholar
  2. 2.
    Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE (2005) Resurgence of pertussis in Europe. Pediatr Infect Dis J 24(9):761–765PubMedCrossRefGoogle Scholar
  3. 3.
    Brooks DA, Clover R (2006) Pertussis infection in the United States: role for vaccination of adolescents and adults. J Am Board Fam Med 19(6):603–611PubMedCrossRefGoogle Scholar
  4. 4.
    Quinn HE, McIntyre PB (2007) Pertussis epidemiology in Australia over the decade 1995–2005–trends by region and age group. Commun Dis Intell 31(2):205–215PubMedGoogle Scholar
  5. 5.
    Han HJ, Kamachi K, Okada K, Toyoizumi-Ajisaka H, Sasaki Y, Arakawa Y (2008) Antigenic variation in Bordetella pertussis isolates recovered from adults and children in Japan. Vaccine 26(12):1530–1534PubMedCrossRefGoogle Scholar
  6. 6.
    Edwards K, Freeman DM (2006) Adolescent and adult pertussis: disease burden and prevention. Curr Opin Pediatr 18(1):77–80PubMedGoogle Scholar
  7. 7.
    Galanis E, King AS, Varughese P, Halperin SA (2006) Changing epidemiology and emerging risk groups for pertussis. CMAJ 174(4):451–452PubMedCrossRefGoogle Scholar
  8. 8.
    Dragsted DM, Dohn B, Madsen J, Jensen JS (2004) Comparison of culture and PCR for detection of Bordetella pertussis and Bordetella parapertussis under routine laboratory conditions. J Med Microbiol 53(Pt 8):749–754PubMedCrossRefGoogle Scholar
  9. 9.
    Mattoo S, Cherry JD (2005) Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18(2):326–382PubMedCrossRefGoogle Scholar
  10. 10.
    Kerr JR, Matthews RC (2000) Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity. Eur J Clin Microbiol Infect Dis 19(2):77–88PubMedCrossRefGoogle Scholar
  11. 11.
    Meade BD, Bollen A (1994) Recommendations for use of the polymerase chain reaction in the diagnosis of Bordetella pertussis infections. J Med Microbiol 41(1):51–55PubMedCrossRefGoogle Scholar
  12. 12.
    Stefani G, Slack FJ (2008) Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 9(3):219–230PubMedCrossRefGoogle Scholar
  13. 13.
    Ruvkun G (2008) The perfect storm of tiny RNAs. Nat Med 14(10):1041–1045PubMedCrossRefGoogle Scholar
  14. 14.
    Zhao L, Chen X, Cao Y (2011) New role of microRNA: carcinogenesis and clinical application in cancer. Acta Biochim Biophys Sin (Shanghai) 43(11):831–839CrossRefGoogle Scholar
  15. 15.
    Shantikumar S, Caporali A, Emanueli C (2011) Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res 93(4):583–593PubMedCrossRefGoogle Scholar
  16. 16.
    Skalsky RL, Cullen BR (2010) Viruses, microRNAs, and host interactions. Annu Rev Microbiol 64:123–141PubMedCrossRefGoogle Scholar
  17. 17.
    Cui L, Guo X, Qi Y, Qi X, Ge Y, Shi Z, Wu T, Shan J, Shan Y, Zhu Z, Wang H (2010) Identification of microRNAs involved in the host response to enterovirus 71 infection by a deep sequencing approach. J Biomed Biotechnol 2010:425939PubMedGoogle Scholar
  18. 18.
    Qi Y, Tu J, Cui L, Guo X, Shi Z, Li S, Shi W, Shan Y, Ge Y, Shan J, Wang H, Lu Z (2010) High-throughput sequencing of microRNAs in adenovirus type 3 infected human laryngeal epithelial cells. J Biomed Biotechnol 2010:915980PubMedCrossRefGoogle Scholar
  19. 19.
    Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Zen K, Zhang CY (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18(10):997–1006PubMedCrossRefGoogle Scholar
  20. 20.
    Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105(30):10513–10518PubMedCrossRefGoogle Scholar
  21. 21.
    Cortez MA, Calin GA (2009) MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther 9(6):703–711PubMedCrossRefGoogle Scholar
  22. 22.
    Liu R, Zhang C, Hu Z, Li G, Wang C, Yang C, Huang D, Chen X, Zhang H, Zhuang R, Deng T, Liu H, Yin J, Wang S, Zen K, Ba Y, Zhang CY (2011) A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer 47(5):784–791PubMedCrossRefGoogle Scholar
  23. 23.
    Zhang C, Wang C, Chen X, Yang C, Li K, Wang J, Dai J, Hu Z, Zhou X, Chen L, Zhang Y, Li Y, Qiu H, Xing J, Liang Z, Ren B, Zen K, Zhang CY (2010) Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin Chem 56(12):1871–1879PubMedCrossRefGoogle Scholar
  24. 24.
    Keller A, Leidinger P, Gislefoss R, Haugen A, Langseth H, Staehler P, Lenhof HP, Meese E (2011) Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol 8(3):506–516PubMedCrossRefGoogle Scholar
  25. 25.
    Liu R, Chen X, Du Y, Yao W, Shen L, Wang C, Hu Z, Zhuang R, Ning G, Zhang C, Yuan Y, Li Z, Zen K, Ba Y, Zhang CY (2012) Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem 58:610–618PubMedCrossRefGoogle Scholar
  26. 26.
    Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK, Johnson JM, Sina JF, Fare TL, Sistare FD, Glaab WE (2009) Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 55(11):1977–1983PubMedCrossRefGoogle Scholar
  27. 27.
    Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE, Galas DJ (2009) Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A 106(11):4402–4407PubMedCrossRefGoogle Scholar
  28. 28.
    Ji F, Yang B, Peng X, Ding H, You H, Tien P (2011) Circulating microRNAs in hepatitis B virus-infected patients. J Viral Hepat 18(7):e242–e251PubMedCrossRefGoogle Scholar
  29. 29.
    Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, Zhang JF, Shen HB, Zhang CY, Zen K (2010) Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 70(23):9798–9807PubMedCrossRefGoogle Scholar
  30. 30.
    Bihrer V, Friedrich-Rust M, Kronenberger B, Forestier N, Haupenthal J, Shi Y, Peveling-Oberhag J, Radeke HH, Sarrazin C, Herrmann E, Zeuzem S, Waidmann O, Piiper A (2011) Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am J Gastroenterol 106(9):1663–1669PubMedCrossRefGoogle Scholar
  31. 31.
    Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, Nicoloso MS, Barbarotto E, Popa M, Stanciulea O, Fernandez MH, Tulbure D, Bueso-Ramos CE, Negrini M, Calin GA (2009) MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS ONE 4(10):e7405PubMedCrossRefGoogle Scholar
  32. 32.
    Wang JF, Yu ML, Yu G, Bian JJ, Deng XM, Wan XJ, Zhu KM (2010) Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun 394(1):184–188PubMedCrossRefGoogle Scholar
  33. 33.
    Fu Y, Yi Z, Wu X, Li J, Xu F (2011) Circulating microRNAs in patients with active pulmonary tuberculosis. J Clin Microbiol 49(12):4246–4251PubMedCrossRefGoogle Scholar
  34. 34.
    Cui L, Qi Y, Li H, Ge Y, Zhao K, Qi X, Guo X, Shi Z, Zhou M, Zhu B, Guo Y, Li J, Stratton CW, Tang YW, Wang H (2011) Serum microRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth disease. PLoS ONE 6(11):e27071PubMedCrossRefGoogle Scholar
  35. 35.
    Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, Anderson B (2009) Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS ONE 4(7):e6229PubMedCrossRefGoogle Scholar
  36. 36.
    Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW, Jing Q (2010) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31(6):659–666PubMedCrossRefGoogle Scholar
  37. 37.
    Kong L, Zhu J, Han W, Jiang X, Xu M, Zhao Y, Dong Q, Pang Z, Guan Q, Gao L, Zhao J, Zhao L (2011) Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol 48(1):61–69PubMedCrossRefGoogle Scholar
  38. 38.
    Riffelmann M, Wirsing von Konig CH, Caro V, Guiso N (2005) Nucleic acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol 43(10):4925–4929PubMedCrossRefGoogle Scholar
  39. 39.
    Sloan LM, Hopkins MK, Mitchell PS, Vetter EA, Rosenblatt JE, Harmsen WS, Cockerill FR, Patel R (2002) Multiplex lightcycler PCR assay for detection and differentiation of Bordetella pertussis and Bordetella parapertussis in nasopharyngeal specimens. J Clin Microbiol 40(1):96–100PubMedCrossRefGoogle Scholar
  40. 40.
    Bamberger E, Lahat N, Gershtein V, Gershtein R, Benilevi D, Shapiro S, Kassis I, Rubin L, Srugo I (2005) Diagnosing pertussis: the role of polymerase chain reaction. Isr Med Assoc J 7(6):351–354PubMedGoogle Scholar
  41. 41.
    Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, Rajewsky N, Bender TP, Rajewsky K (2007) MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131(1):146–159PubMedCrossRefGoogle Scholar
  42. 42.
    Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, Schmidt-Supprian M, Rajewsky N, Yancopoulos G, Rao A, Rajewsky K (2007) Regulation of the germinal center response by microRNA-155. Science 316(5824):604–608PubMedCrossRefGoogle Scholar
  43. 43.
    Ma F, Xu S, Liu X, Zhang Q, Xu X, Liu M, Hua M, Li N, Yao H, Cao X (2011) The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma. Nat Immunol 12(9):861–869PubMedCrossRefGoogle Scholar
  44. 44.
    Lu TX, Hartner J, Lim EJ, Fabry V, Mingler MK, Cole ET, Orkin SH, Aronow BJ, Rothenberg ME (2011) MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol 187(6):3362–3373PubMedCrossRefGoogle Scholar
  45. 45.
    Bandyopadhyay S, Friedman RC, Marquez RT, Keck K, Kong B, Icardi MS, Brown KE, Burge CB, Schmidt WN, Wang Y, McCaffrey AP (2011) Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture. J Infect Dis 203(12):1753–1762PubMedCrossRefGoogle Scholar
  46. 46.
    van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 105(35):13027–13032PubMedCrossRefGoogle Scholar
  47. 47.
    Wei J, Gao W, Zhu CJ, Liu YQ, Mei Z, Cheng T, Shu YQ (2011) Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chin J Cancer 30(6):407–414PubMedCrossRefGoogle Scholar
  48. 48.
    Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS, Sung JJ (2009) Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58(10):1375–1381PubMedCrossRefGoogle Scholar
  49. 49.
    Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 (7):RESEARCH0034Google Scholar
  50. 50.
    Wu F, Zhang S, Dassopoulos T, Harris ML, Bayless TM, Meltzer SJ, Brant SR, Kwon JH (2010) Identification of microRNAs associated with ileal and colonic Crohn’s disease. Inflamm Bowel Dis 16(10):1729–1738PubMedCrossRefGoogle Scholar
  51. 51.
    Brase JC, Johannes M, Schlomm T, Falth M, Haese A, Steuber T, Beissbarth T, Kuner R, Sultmann H (2011) Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer 128(3):608–616PubMedCrossRefGoogle Scholar
  52. 52.
    Zahm AM, Thayu M, Hand NJ, Horner A, Leonard MB, Friedman JR (2011) Circulating microRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr 53(1):26–33PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Yiyue Ge
    • 1
    • 2
  • Kangchen Zhao
    • 1
  • Yuhua Qi
    • 1
  • Xiaoyan Min
    • 3
  • Zhiyang Shi
    • 1
  • Xian Qi
    • 1
  • Yunfeng Shan
    • 1
  • Lan Cui
    • 1
  • Minghao Zhou
    • 1
  • Yong Wang
    • 2
  • Hua Wang
    • 1
  • Lunbiao Cui
    • 1
  1. 1.Institute of Pathogen Microbiology, Jiangsu Provincial Center for Disease Prevention and Control, Key Laboratories of Enteric Pathogenic Microbiology, Ministry of HealthNanjingChina
  2. 2.Department of Pathogen BiologyNanjing Medical UniversityNanjingChina
  3. 3.Department of GeriatricsThe First Affiliated Hospital, Nanjing Medical UniversityNanjingChina

Personalised recommendations